TARCIC, NORA,BAR-ZOHAR, DAN,KOFLER, DINA,TARCIC, Nora,BAR-ZOHAR, Dan,KOFLER, Dina
申请号：
RSP20150645
公开号：
RS54328B1
申请日:
2010.06.18
申请国别(地区):
RS
年份:
2016
代理人:
摘要：
The subject invention provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient, the method comprising orally administering to the patient a daily dose of 0.6 mg laquinimod. The subject invention also provides for pharmaceutical oral unit dosage forms of 0.6 mg laquinimod for use in reducing the relapse rate and/or for use in reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient.Lakvinimod za upotrebu u smanjenju stope relapsa i(li) smanjenju akumulacije fizičkog invaliditeta koji se procenjuju pomoću vremena koje protekne do potvrđenog napretka bolesti kod pacijenata - ljudi koji pate od multiple skleroze sa relapsima i remisijama, naznačen time što se navedeni lakvinimod priprema za primenu u doznom režimu od 0,6 mg lakvinimoda dnevno.Prijava sadrži još 13 patentnih zahteva.
